PERSPECTA

News from every angle

Back to headlines

CICC Initiates 'Outperform' Rating for Pfizer

CICC has begun its coverage of pharmaceutical giant Pfizer Inc. (PFE) with an 'Outperform' rating, signaling a positive outlook for the company's stock.

20 Apr, 21:34 — 20 Apr, 21:34
PostShare

Sources

Showing 1 of 1 sources